Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).
Adams D, Cintas P, Solé G, Tard C, Labeyrie C, Echaniz-Laguna A, Cauquil C, Pereon Y, Magy L, Morales RJ, Antoine JC, Lagrange E, Petiot P, Mallaret M, Francou B, Guiochon-Mantel A, Coste A, Demarcq O, Geffroy C, Famelart V, Rudant J, Bartoli M, Donal E, Lairez O, Eicher JC, Kharoubi M, Oghina S, Trochu JN, Inamo J, Habib G, Roubille F, Hagège A, Morio F, Cariou E, Adda J, Slama MS, Charron P, Algalarrondo V, Damy T, Attarian S. Adams D, et al. Among authors: damy t. Rev Neurol (Paris). 2024 Apr 19:S0035-3787(24)00489-2. doi: 10.1016/j.neurol.2024.02.393. Online ahead of print. Rev Neurol (Paris). 2024. PMID: 38643028
[Transthyretin cardiac amyloidosis].
Eicher JC, Audia S, Damy T. Eicher JC, et al. Among authors: damy t. Rev Med Interne. 2020 Oct;41(10):673-683. doi: 10.1016/j.revmed.2020.07.002. Epub 2020 Aug 18. Rev Med Interne. 2020. PMID: 32826087 Review. French.
Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases.
Damy T, Bourel G, Slama M, Algalarrondo V, Lairez O, Fournier P, Costa J, Pelcot F, Farrugia A, Zaleski ID, Lilliu H, Rault C, Bartoli M, Fievez S, Granghaud A, Rudant J, Coste A, Cosson CN, Squara PA, Narbeburu M, De Neuville B, Charron P. Damy T, et al. Orphanet J Rare Dis. 2023 Nov 6;18(1):345. doi: 10.1186/s13023-023-02933-w. Orphanet J Rare Dis. 2023. PMID: 37926810 Free PMC article.
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.
Damy T, Costes B, Hagège AA, Donal E, Eicher JC, Slama M, Guellich A, Rappeneau S, Gueffet JP, Logeart D, Planté-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Randé JL, Goossens M, Canoui-Poitrine F, Buxbaum JN. Damy T, et al. Eur Heart J. 2016 Jun 14;37(23):1826-34. doi: 10.1093/eurheartj/ehv583. Epub 2015 Nov 3. Eur Heart J. 2016. PMID: 26537620 Clinical Trial.
Fabry disease in cardiology practice: Literature review and expert point of view.
Hagège A, Réant P, Habib G, Damy T, Barone-Rochette G, Soulat G, Donal E, Germain DP. Hagège A, et al. Among authors: damy t. Arch Cardiovasc Dis. 2019 Apr;112(4):278-287. doi: 10.1016/j.acvd.2019.01.002. Epub 2019 Feb 28. Arch Cardiovasc Dis. 2019. PMID: 30826269 Free article. Review.
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis.
Bézard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Gendre T, Audard V, El Karoui K, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Planté-Bordeneuve V, Oghina S, Damy T. Bézard M, et al. Among authors: damy t. Eur J Heart Fail. 2021 Feb;23(2):264-274. doi: 10.1002/ejhf.2028. Epub 2020 Nov 9. Eur J Heart Fail. 2021. PMID: 33094885 Free article.
Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).
Mirabel M, Damy T, Donal E, Huttin O, Labombarda F, Eicher JC, Cervino C, Laurito M, Offredo L, Tafflet M, Jouven X, Giura G, Desnos M, Jeunemaître X, Empana JP, Charron P, Habib G, Réant P, Hagège A; REMY working group of the French Society of Cardiology. Mirabel M, et al. Among authors: damy t. Int J Cardiol. 2019 Jan 15;275:107-113. doi: 10.1016/j.ijcard.2018.09.083. Epub 2018 Sep 28. Int J Cardiol. 2019. PMID: 30316646
Association between hearing loss and hereditary ATTR amyloidosis.
Bartier S, Bodez D, Kharoubi M, Guellich A, Canouï-Poitrine F, Chatelin V, Coste A, Damy T, Béquignon E. Bartier S, et al. Among authors: damy t. Amyloid. 2019 Dec;26(4):234-242. doi: 10.1080/13506129.2019.1663814. Epub 2019 Sep 10. Amyloid. 2019. PMID: 31502881
Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY).
Hourqueig M, Bouzille G, Mirabel M, Huttin O, Damy T, Labombarda F, Eicher JC, Charron P, Habib G, Réant P, Hagège A, Donal E; REMY working group of the French Society of Cardiology. Hourqueig M, et al. Among authors: damy t. Clin Res Cardiol. 2022 Feb;111(2):163-174. doi: 10.1007/s00392-020-01797-5. Epub 2021 May 27. Clin Res Cardiol. 2022. PMID: 34043053
261 results